Company / Book Value per Share
Revolution Medicines, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$8.775
FY2025
5-year range
-$2.291 / $20.199
FY2021-FY2025
Trend
-36.2%
vs FY2024
Sector context
#66 of 209
Health Care
What the data says
At $8.775, Revolution Medicines, Inc.'s book value per share ranks #66 of 209 in the Health Care sector. Declined from $20.199 to $8.775 over the past 2 years.
Based on SEC 10-K filings.
$8.775 in FY2025 with a 3-year CAGR of +11.1%.
Declined from $20.199 to $8.775 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#66 of 209 in Health CareTop 32% of 209This company $8.775 Sector average $215.686
▼
-95.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +11.1%, indicating consistent growth.
- In FY2025, book value per share decreased 36.2% year-over-year.
- Ranks #66 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.775 | -36.2% |
| FY2024 | $13.756 | -31.9% |
| FY2023 | $20.199 | +215.5% |
| FY2022 | $6.402 | +379.5% |
| FY2021 | -$2.291 | +93.0% |
| FY2020 | -$32.934 | +40.2% |
| FY2019 | -$55.029 | -16.7% |
| FY2018 | -$47.164 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026